A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Montelukast is one of leukotriene (LT) receptor antagonists, which is safe and effective drug as a combined systemic and topical treatment regimen for treatment of moderate-to-severe atopic dermatitis (AD). The present study aimed to evaluate the role of montelukast treatment in modulation of filaggrin R501X and 2282derl4 mutations in Egyptian patients with atopic dermatitis. Total of (32) patients with AD and 16 healthy non-AD volunteers with no allergic disease were enrolled in this study.doi:10.7324/japs.2014.40103 fatcat:kou5dojsobdwre77atwmmmszce